Skip to main content
Promino Nutritional Sciences Inc. logo

Promino Nutritional Sciences Inc. — Investor Relations & Filings

Ticker · MUSL ISIN · CA74290V2049 CSE Manufacturing
Filings indexed 217 across all filing types
Latest filing 2024-03-04 Regulatory Filings
Country CA Canada
Listing CSE MUSL

About Promino Nutritional Sciences Inc.

https://drinkpromino.com/

Promino Nutritional Sciences Inc. is a research-driven nutraceutical company specializing in the development and distribution of science-based, clinically proven nutritional products for muscle health and recovery. The company focuses on patented formulations of essential amino acids (EAAs) designed to optimize muscle protein synthesis (MPS). Its flagship product, Promino™, is a consumer supplement that delivers a precise ratio and potency of all nine EAAs, demonstrated to be significantly more effective than traditional protein sources like whey. Promino's products target athletes and individuals seeking metabolic health improvements. The company also explores clinical applications, such as retaining muscle mass in cancer patients undergoing chemotherapy.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Kirk McLean, a former NHL player, has joined Promino Nutritional Sciences Inc. as a Brand Ambassador. It also announces new corporate and fiscal advisory agreements and provides background information about the company and its products. There is no financial data, no regulatory filing references, no meeting materials, no voting results, no audit or financial reports, no earnings release, no legal proceedings, no capital or financing updates, and no other specific regulatory or financial report content. The document is a general corporate announcement and marketing communication rather than a formal financial or regulatory filing. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other specific categories.
2024-03-04 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the start of shipment of a product (Rejuvenate Muscle™ Drink Mix) by Promino Nutritional Sciences Inc. It discusses product details, company background, and forward-looking statements. There is no indication of financial data, regulatory filings, shareholder votes, management changes, or any formal report. The content is promotional and informational about product distribution and company strategy, typical of a general regulatory announcement or news release. It does not fit into categories like Annual Report, Earnings Release, or Investor Presentation. Given the nature and length, it best fits the Regulatory Filings (RNS) category as a general announcement that does not fit other specific categories.
2024-02-27 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of a $2.2 million private placement capital raise by Promino Nutritional Sciences Inc. It details the terms of the offering, including the number of units issued, pricing, warrants, and use of proceeds. Additionally, it announces a brand ambassador agreement with NHL player Jack Eichel and a marketing agreement renewal. The content focuses on financing activities and related corporate announcements rather than financial results, regulatory filings, or management reports. There is no indication that this is a full financial report or an earnings release. The primary subject is the capital raise and related agreements, which fits the Capital/Financing Update category.
2024-02-12 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing a private placement financing by Promino Nutritional Sciences Inc. It details the terms of the offering, use of proceeds, and includes forward-looking statements. There are no financial statements or detailed financial analysis present. The document is focused on capital raising activities and financing terms, which aligns with the Capital/Financing Update category. The length is 8405 characters, sufficient for a detailed announcement but not a full financial report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2024-01-27 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a corporate name change and ticker symbol change for Promino Nutritional Sciences Inc. It contains no financial statements, no detailed financial data, no regulatory filings, no voting results, no management or board changes, and no mention of any report publication. The content is primarily an announcement of a corporate identity update and forward-looking statements about the company's prospects. The document length is under 5,000 characters and does not contain any report or financial data. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a general Regulatory Filing (RNS) as a miscellaneous corporate announcement that does not fit other categories.
2024-01-27 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a planned name change of the company Element Nutritional Sciences Inc. to Promino Nutritional Sciences Inc. It includes details about the name change, the company's business, and forward-looking statements. There are no financial statements, regulatory filings, voting results, or other report types present. The document is an announcement of a corporate action (name change) rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or others related to financial data or governance changes. The closest fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-01-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.